ArticleAustralian "Gene Patenting" Case To Be AppealedThe patenting of human genes in Australia remains under court review. AustraliaFood, Drugs, Healthcare, Life SciencesFoley & Lardner LLP
ArticleEU General Data Protection (GDPR) (Regulation 2016/679) - How is this relevant to the Australian health and lifesciences sector?The GDPR applies to all member EU states and to organisations outside the EU who process data of individuals in the EU.AustraliaFood, Drugs, Healthcare, Life SciencesHolman Webb
ArticlePfizer Files Lawsuit In Australia To Halt Sales Of BRENZYS (Etanercept)Last week Pfizer filed a lawsuit in a federal court of Australia against respondents Samsung Bioepis, Merck, Sharp & Dohme, Organon, and Arrow, to halt sales of their biosimilar BRENZYS (etanercept).AustraliaIntellectual PropertyGoodwin Procter LLP
ArticleGene Patent Modifications AvoidedA long awaited Australian Senate committee report into gene patenting has recently been released, providing totally inconclusive results, meaning the status quo on gene patents is maintained for now. The terms of reference for the inquiry directed the Committee to consider the impacts of gene patents on healthcare, medical research and the health and wellbeing of Australians.AustraliaIntellectual PropertySpruson & Ferguson Lawyers
ArticleAustralia Biotech Week Showcases Sophistication And GrowthOn October 9, Australia's biotech community completed its annual pilgrimage to Melbourne at the conclusion of Australia Biotech Invest 2015 and AusBiotech 2015.AustraliaFood, Drugs, Healthcare, Life SciencesDentons
ArticleMyriad Posts Gene Patenting Victory In AustraliaIn a companion case to the "gene patenting" dispute presently before the U.S. Supreme Court, Myriad Genetics, Inc. successfully defended the patent-eligibility of "gene patents" in Australia. AustraliaFood, Drugs, Healthcare, Life SciencesFoley & Lardner LLP
ArticleFederal Government To Introduce A "Patent Box" Tax Regime In AustraliaThe Federal Government has announced that it will introduce a "patent box" tax regime from 1 July 2022 to encourage investment and innovation in Australia in the medical and biotechnology sectors. AustraliaIntellectual PropertyDavies Collison Cave
ArticleInternational Biosimilar Market UpdatesStelis Biopharma Receives Positive Recommendation for FORSTEO Biosimilar in Europe.GlobalFood, Drugs, Healthcare, Life SciencesGoodwin Procter LLP
Article'Challenges in regulating biotechnology' flagged as a key issue for the new Australian ParliamentThe Parliamentary Librarian presents strategic level snapshots of some issues expected to feature in the new Parliament.AustraliaGovernment, Public SectorFB Rice
ArticleDCCL Resource Centre: Issue 10This newsletter contains helpful up-to-date resources for our clients. AustraliaIntellectual PropertyDavies Collison Cave
ArticleDid a gene patent save Angelina Jolie's life?This recent news has increased the intensity of the spotlight on the gene patent debate in both the US and Australia.AustraliaIntellectual PropertySpruson & Ferguson Lawyers
ArticleUpdate in the US Supreme Court landmark Myriad gene patent caseThe decision is considering the patentability of isolated human genes claimed in patents held by Myriad Genetics, Inc.AustraliaIntellectual PropertySpruson & Ferguson Lawyers
ArticleChina med tech’s growing global appetite swallows Australian distributor Ulco MedicalChina's med tech companies such as Mindray are expanding globally from their initial focus on Chinese domestic markets.AustraliaInternational LawFB Rice
ArticleHCF And The ´Helping Hand´ DecisionThe Privacy Commissioner recently conducted an investigation into the disclosure of personal information by a private health insurance company, HCF, to McKesson Asia Pacific, a third party involved in the health fund's Helping Hands program. AustraliaGovernment, Public SectorMinter Ellison
ArticleAustralian High Court Rules Gene Patents UnpatentableLike the United States Supreme Court, the High Court of Australia has determined that Myriad's patents directed to purified and isolated DNA molecules encoding the BRCA genes are unpatentable.AustraliaIntellectual PropertyBakerHostetler
ArticleAustralian Federal Court Upholds Myriad’s Gene PatentWhile the question of patentability of isolated gene sequences awaits resolution at the U.S. Supreme Court, the Australian Federal Court today upheld Myriad Genetics’ patent on methods for screening for cancer-predisposing mutations in the BRCA1 gene. AustraliaFood, Drugs, Healthcare, Life SciencesMorrison Foerster
ArticleAustralian Regulation Banning Animal Testing For Cosmetic ProductsMany basic rights exist to protect people. These fundamental human rights cover what most consider and think of as being the rights of every man ...AustraliaFood, Drugs, Healthcare, Life SciencesSTA Law Firm
ArticleHealth law alert from Holman Webb: welcome to the April 2018 editionArticle discusses health law issues such as mandatory data breach notifications, private health insurance reform etc.AustraliaFood, Drugs, Healthcare, Life SciencesHolman Webb
ArticleLabelling Of Complementary MedicinesThe Trade Practices Act includes strict provisions stipulating how and when a product, including a medicinal product, can be said to be "made in Australia".AustraliaFood, Drugs, Healthcare, Life SciencesClayton Utz